Linked Life Data

17239289

Source:http://linkedlifedata.com/resource/pubmed/id/17239289

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-1-22
pubmed:abstractText
Many novel targeted agents have emerged against a variety of malignancies. Although papulopustular rash is the most commonly observed side effect associated with many of these agents, several non-rash skin toxicities have been identified that frequently result in the delay or discontinuation of anticancer therapy. These toxicities include skin hyperpigmentation, xerosis, pruritus, hair growth and color abnormalities, periungual and nail alterations, and hand-foot skin reaction. It is important to recognize these toxicities, so that they can be diagnosed early and treatment or dose modification can be initiated, if necessary. This review discusses several non-rash dermatologic toxicities observed with targeted therapeutic agents and guidelines for their diagnosis and treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1525-7304
pubmed:author
pubmed:issnType
Print
pubmed:volume
8 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S36-42
pubmed:dateRevised
2008-12-12
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Non-rash skin toxicities associated with novel targeted therapies.
pubmed:affiliation
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 48201, USA.
pubmed:publicationType
Journal Article, Review